Actinium Pharmaceuticals, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference

ConferenceNeutral

AI Analysis

Summary

Actinium Pharmaceuticals announced that its Chairman and CEO Sandesh Seth will present at the H.C. Wainwright 28th Annual Global Investment Conference. The company is a developer of targeted radiotherapies.

Importance:2/10

Sentiment:

0.00

conference presentationinvestor relationsradiotherapy

Related Companies

$ATNM

Read the original article

Published by PR Newswire Pharma on September 4, 2026 9:05 PM

Read Original